𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases

✍ Scribed by S. Benoist; K. Pautrat; E. Mitry; P. Rougier; C. Penna; B. Nordlinger

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
112 KB
Volume
92
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antipyrine metabolism in patients with l
Antipyrine metabolism in patients with liver metastases from colorectal cancer
✍ Antonio Grieco; Carlo Barone; Paola Coletta; Rosario Castellano; Enzo Ragazzoni; πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 490 KB πŸ‘ 2 views

## Background: The influence of cancer on antipyrine metabolism is under debate. ## Methods: To assess the functional activity of a liver with solid metastases from primary colorectal cancer, antipyrine metabolism was studied after the drug was administered orally (18 mg/kg body weight) to 55 hea

Prognostic index for the development of
Prognostic index for the development of liver metastases in patients with colorectal cancer
✍ Professor I. Taylor; M. A. Mullee; M. J. Campbell πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 280 KB πŸ‘ 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m